Karger Image Explorer
Unlock visual excellence with Karger Image Explorer, featuring over 260,000 peer-reviewed images from our esteemed journals. Easily find high-quality visuals, obtain licensing information and request reuse permissions to achieve your goals quickly and efficiently.
Research Viewpoints
Discover highlights from the latest scientific research, interviews with leading scientists, the latest developments from Karger and across the publishing industry in our research blog.
CCORC 2025: Call for Abstracts and Session Proposals
Submission Deadline: February 19, 2025, 11:59 PM EST
The Consortium for Medical Marijuana Clinical Outcomes Research is now accepting abstracts and session proposal submissions for the fifth annual Cannabis Clinical Outcomes Research Conference (CCORC) on May 29-30, 2025.
All submissions will be peer-reviewed and top abstracts will be invited for oral presentations. All abstracts accepted by the conference will be published in Medical Cannabis and Cannabinoids.
Abstracts and posters submitted by students will be considered for awards presented on the final day of the conference. Student presenters from Consortium member universities are eligible to apply for travel support.
Please reach out to [email protected] with any questions.
IMCCB-25
Building on the success of previous Swiss cannabis congresses, IMCCB-25 aspires to bring together a diverse assembly of leading researchers, clinicians, industry professionals, and other experts and opinion leaders from around the world. The conference takes place at the University of Bern, Switzerland, February 13–14, 2025.
New Tool for Evaluating Potential Drug-Drug Interactions Based on Cannabinoids
CANNabinoid Drug Interaction Review (CANN-DIR®), developed at Penn State College of Medicine, is intended to evaluate for potential drug-drug interactions based on the cannabinoids (THC & CBD) affecting the metabolism of OTHER concomitantly prescribed medications. This tool has been developed for use by healthcare providers, patients, caregivers, and interested community members. Medical Cannabis and Cannabinoids has published a product review on this tool: Drug Interaction Review (CANN-DIR™), utilizing research published in the review Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions, appearing earlier in the journal.
